Amphastar Pharmaceuticals, Inc.
AMPH
$23.04
$0.110.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 372.71% | -73.72% | 40.80% | -44.09% | 22.72% |
| Total Depreciation and Amortization | -0.19% | 3.16% | 1.39% | -2.90% | 6.79% |
| Total Amortization of Deferred Charges | 14.98% | -12.12% | -2.15% | 5.11% | 10.50% |
| Total Other Non-Cash Items | -29.81% | -74.17% | 421.19% | 9.61% | -43.00% |
| Change in Net Operating Assets | -116.85% | 135.82% | -456.16% | 164.76% | -10.84% |
| Cash from Operations | 7.28% | 45.57% | -37.50% | 47.74% | 1.47% |
| Capital Expenditure | 9.64% | -14.93% | -54.67% | 49.38% | 1.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 839.84% | 86.18% | -266.46% | -243.57% | -53.06% |
| Cash from Investing | 368.15% | 72.37% | -208.73% | -3,039.04% | -105.96% |
| Total Debt Issued | -- | -- | 58.72% | -95.83% | 151.46% |
| Total Debt Repaid | -1,710.34% | 72.12% | -136.36% | -18.92% | 2.63% |
| Issuance of Common Stock | -- | -- | 422.96% | -23.28% | -- |
| Repurchase of Common Stock | -47.55% | -47.09% | -323.01% | 85.96% | -120.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 98.42% | 40.05% |
| Cash from Financing | -44.12% | -64.41% | -322.66% | 85.61% | -108.25% |
| Foreign Exchange rate Adjustments | 111.59% | -1,433.33% | 78.05% | -128.87% | 20.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,812.73% | 101.65% | -261.28% | 482.35% | -84.26% |